Document Type : Research Paper

Authors

1 Ph.D. Student in Exercise Physiology, University of Guilan

2 Professor of Sport Physiology, University of Guilan

3 Professor of Exercise Physiology, University of Isfahan

Abstract

The prevalence of overweight and obesity has increased diabetes around the world. Previous researches emphasized the effect of regular training in increasing insulin sensitivity and improving glucose metabolism. However, the purpose of this study was to investigate the effect of eight-week resistance and aerobic training on lipid profile and serum levels of hepatokine HFREP1 in obese men with type 2 diabetes. 34 participants with type 2 diabetes were randomly assigned to three groups of aerobic training (BMI 33.40± 3.33 kg/m2, age of 52.41± 1.83), resistance (BMI 31.20± 1.20 kg/m2, age of 52.45± 1.5) groups and a control group (BMI 32.60± 2.88 kg/m2, age of 53.09± 1.13). The experimental groups did eight-week aerobic and resistance training. In this study HFREP1, FBS, HbA1c, HOMA-IR, triglycerides (TG), total cholesterol (TC), high-density lipoprotein (HDL) and low-density lipoprotein (LDL) were measured before and after the training period by applying ELISA test, HPLC, and Enzyme photometric. Then, assigning the normality through Shapiro-Wilk test, ANCOVA test and Bonferroni test were applied to compare data between three groups. Furthermore, the significant level for analyzing data was p˂0.05. Also, in all factors except TC, HOMA-IR, HDL, and LDL there was a significant difference between resistance and endurance groups (p˂0.05). resistance and aerobic training had a significant effect on Insulin resistance and lipid profile; and eight-week resistance and aerobic training lead to decreasing in HFREP1, FBS, HbA1c, HOMA-IR, TG, and LDL while HDL increased. Although resistance and aerobic training have an effect on Insulin resistance and lipid profile, it seems that the effect of resistance training on above-mentioned variables is superior.

Keywords

Main Subjects

  1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes care. 2010;33(Suppl 1): 62.
  2. Stefan N, Häring HU. The role of hepatokines in metabolism. NRE. 2013;9(3):144-52.
  3. Nordlie RC, Foster JD, Lange AJ. Regulation of glucose production by the liver. ARN. 1999;19(1):379-406.
  4. Fazeli PK, Lun M, Kim SM, Bredella MA, Wright S, Zhang Y, et al. FGF21 and the late adaptive response to starvation in humans. J Clin Invest. 2015;125(12):4601-11.
  5. Dushay J, Chui PC, Gopalakrishnan GS, Varela–Rey M, Crawley M, Fisher FM, et al. Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology. 2010;139(2):456-63.
  6. Kim SH, Kim KH, Kim HK, Kim MJ, Back SH, Konishi M, et al. Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress. Diabetologia. 2015;58(4):809-18.
  7. Lauro D, Kido Y, Castle AL, Zarnowski MJ, Hayashi H, Ebina Y, et al. Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue. NG. 1998;20(3):294-8.
  8. Meex RC, Hoy AJ, Morris A, Brown RD, Lo JC, Burke M, Goode RJ, Kingwell BA, Kraakman MJ, Febbraio MA, Greve JW. Fetuin B is a secreted hepatocyte factor linking steatosis to impaired glucose metabolism. Cell Metab. 2015;22(6):1078-89.
  9. Iroz A, Couty JP, Postic C. Hepatokines: Unlocking the multi-organ network in metabolic diseases. Diabetologia. 2015;58(8):1699-703.
  10. Yamada T, Katagiri H. Avenues of communication between the brain and tissues/organs involved in energy homeostasis. Endocrine J. 2007;54(4):497-505.
  11. Lu FH, Ou HY, Wu HT, Hung HC, Wu JS, Yang YC, et al. Serum hepassocin concentrations in diabetic patients with or without nonalcoholic fatty liver disease. Diabetes Manag. 2014;4(3):255.
  12. Wu HT, Ou HY, Hung HC, Su YC, Lu FH, Wu JS, et al. A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes. Diabetologia. 2016;59(8):1732-42.
  13. Roskoski Jr R. ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol Res. 2012;66(2):105-43.
  14. Marcus RL, Smith S, Morrell G, Addison O, Dibble LE, Wahoff-Stice D, et al. Comparison of combined aerobic and high-force eccentric resistance exercise with aerobic exercise only for people with type 2 diabetes mellitus. Phys Ther. 2008;88(11):1345-54.
  15. Praet SF, Van Loon LJ. Optimizing the therapeutic benefits of exercise in type 2 diabetes. J Appl Physiol. 2007;103(4):1113-20.
  16. Stewart KJ. Exercise training: can it improve cardiovascular health in patients with type 2 diabetes? British J Sports Med. 2004 ;38(3):250-2.
  17. Ahmadizad S, Haghighi AH, Hamedinia MR. Effects of resistance versus endurance training on serum adiponectin and insulin resistance index. Eur J Endocrinol. 2007;157(5):625-31.
  18. Shenoy S, Arora E, Jaspal S. Effects of progressive resistance training and aerobic exercise on type 2 diabetics in Indian population. Int J Diab Metab. 2009;17(1):    27-30.
  19. Castaneda C, Layne JE, Munoz-Orians L, Gordon PL, Walsmith J, Foldvari M, et al. A randomized controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes. Diabetes Care. 2002;25(12):2335-41.
  20. Arora E, Shenoy S, Sandhu JS. Effects of resistance training on metabolic profile of adults with type 2 diabetes. Indian J Med Res. 2009;129(5):515.
  21. Yardley JE, Kenny GP, Perkins BA, Riddell MC, Balaa N, Malcolm J, et al. Resistance versus aerobic exercise: Acute effects on glycemia in type 1 diabetes. Diabetes Care. 2013;36(3):537-42.
  22. Hansen D, Dendale P, Jonkers RA, Beelen M, Manders RJ, Corluy L, et al. Continuous low-to moderate-intensity exercise training is as effective as moderate-to high-intensity exercise training at lowering blood HbA1c in obese type 2 diabetes patients. Diabetologia. 2009;52(9):1789-97.
  23. Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C. Physical activity/exercise and type 2 diabetes. Diabetes Care. 2004;27(10):2518-39.
  24. Aagaard P, Simonsen EB, Andersen JL, Magnusson P, Dyhre-Poulsen P. Increased rate of force development and neural drive of human skeletal muscle following resistance training. J Appl Physiol. 2002;93(4):1318-26.
  25. Kraemer WJ, Fry AC, Ratamess N, French D. Strength testing: development and evaluation of methodology. Physiol Assess Hum Fit. 1995;2:119-50.
  26. Alam S, Stolinski M, Pentecost C, Boroujerdi MA, Jones RH, Sonksen PH, et al. The effect of a six-month exercise program on very low-density lipoprotein apolipoprotein B secretion in type 2 diabetes. J Clin Endocrinol Metab. 2004;89(2):688-94.
  27. Cauza E, Hanusch-Enserer U, Strasser B, Ludvik B, Metz-Schimmerl S, Pacini G, et al. The relative benefits of endurance and strength training on the metabolic factors and muscle function of people with type 2 diabetes mellitus. Arch Phys Med Rehab. 2005;86(8):1527-33.
  28. Praet SF, Van Loon LJ. Optimizing the therapeutic benefits of exercise in type 2 diabetes. J Appl Physiol. 2007;103(4):1113-20.
  29. Nasiri S, Banitalebi E, Faramarzi M, Rabiei V. Study of blood sugar and lipid profile changes after eight weeks of combined training in women with type 2 diabetes. J Jiroft Univ Med Sci. 2017;3(2):114-24. (In Persian).
  30. Ghorbani A, Ziaee A, Yazdi Z, Khoeyni MH, Khoshpanjeh M. Effects of short-term exercise program on blood glucose, lipids, and hba1c in type 2 diabetes. Iranian J Diab Obes. 2012;4(1):19-25. (In Persian).
  31. Bweir S, Al-Jarrah M, Almalty AM, Maayah M, Smirnova IV, Novikova L, Stehno-Bittel L. Resistance exercise training lowers HbA1c more than aerobic training in adults with type 2 diabetes. Diabetology & Metabolic Syndrome. 2009;1(1):27.
  32. Choi K, Kim YB. Molecular mechanism of insulin resistance in obesity and type 2 diabetes. Korean J Intern Med. 2010;25(2):119.
  33. Wang Y, Simar D, Fiatarone Singh MA. Adaptations to exercise training within skeletal muscle in adults with type 2 diabetes or impaired glucose tolerance: A systematic review. Diab Metab Res Rev. 2009;25(1):13-40.
  34. Behboudi L, Azarbayjani MA, Aghaalinejad H, Salavati M. Effects of aerobic exercise and whole-body vibration on glycaemia control in type 2 diabetic males. Asian J Sports Med. 2011;2(2):83.
  35. Black LE, Swan PD, Alvar BA. Effects of intensity and volume on insulin sensitivity during acute bouts of resistance training. J Strength Cond Res. 2010;24(4):1109-16.
  36. Bacchi E, Negri C, Zanolin ME, Milanese C, Faccioli N, Trombetta M, et al.  Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: A randomized controlled trial (the RAED2 study). Diabetes Care. 2012;35(4):676-82.
  37. Shenoy S, Arora E, Jaspal S. Effects of progressive resistance training and aerobic exercise on type 2 diabetics in Indian population. Int J Diab Metab. 2009;17(1):   27-30.
  38. Balducci S, Leonetti F, Di Mario U, Fallucca F. Is a long-term aerobic plus resistance training program feasible for and effective on metabolic profiles in type 2 diabetic patients? Diabetes Care. 2004;27(3):841-2.
  39. Yang K, Bernardo LM, Sereika SM, Conroy MB, Balk J, Burke LE. Utilization of 3-month yoga program for adults at high risk for type 2 diabetes: A pilot study. Evid-Based Complem Altern Med. 2011;22(2):1-6.
  40. Esfarjani F, Rashidi F, Marandi SM. The effect of aerobic exercise on blood glucose, Lipid Profile and Apo. J Ardabil Univ Med Sci. 2013;13(2):132-41.